After announcing plans to go public, prescription digital therapeutics (DTx) firm Better Therapeutics has begun a “real world” study to test whether its BT-001 prescription cognitive behavioural therapy tool could change behaviours that are the root cause of type 2 diabetes. The company has begun… Read More »Better Therapeutics begins ‘real world’ study of digital diabetes therapy
The first quarter of 2021 has been one of investor optimism as the vaccine rollout continues ahead of expectations and economic activity begins to accelerate in response. Within the Health IT industry, the already strong investment and M&A trends seen in 2020 have only accelerated. Over the… Read More »Q1 2021 Health IT/Digital Health PC/VE, M&A, IPOs/ SPACs Activity
Digital health startup Better Therapeutics plans to go public through a SPAC merger that would value it at $187 million. The company is currently running a pivotal study to see if its app-based program could be used as a treatment for type 2 diabetes.
Anyone who follows me knows that I’ve been questioning whether digital therapeutics are real and more importantly whether the people building and trying to sell them are simply trying to replicate the American drug pricing model–patent, protect, prescribe & price gouge. So who better to… Read More »Digital Therapeutics, Megan & Me!
Akili has published data backing the efficacy of its childhood attention-deficit hyperactivity disorder (ADHD) video game therapy EndeavorRx in the peer-review journal Nature Digital Medicine. The results come from the STARS-Adjunct trial, an open-label study of EndeavorRx (AKL-T01) that supported approval of the app and… Read More »Akili’s gaming therapy improves attention in ADHD kids
Earlier this year, AppliedVR shared results of a pivotal study that it plans to submit to the FDA. It received a breakthrough device designation last year to use its VR platform to treat fibromyalgia and lower back pain.
“Gamification” – adding game-like elements into non-game or real-world settings – has become a popular concept in the pharmaceutical, healthcare, and event industries, especially as virtual engagement becomes more common during COVID-19. However, it is proving more than a mere buzzword. With diverse applications and… Read More »Gamification for patient care, medical education, and virtual engagement
European digital health firm Epillo is to launch a pilot digital therapeutics (DTx) project in a strategic partnership with US-based blockchain firm Hydrus7 Labs. Epillo’s technology is based around a patient-facing software apps that help patients treat, prevent, or manage the disease. The company said… Read More »Epillo to pilot blockchain-based DTx with Hydrus7
Wellstar Health System, one of Georgia’s largest and most integrated healthcare systems, and Sharecare, the digital health company that helps people manage all their health in one place, announced a strategic partnership to collaborate on unique, market-leading innovations in personalized care delivery, population health, and… Read More »Wellstar Invests $10M to Become First Sharecare-Enabled Health System
Otsuka Pharmaceutical is partnering with Click Therapeutics to launch a remote clinical trial to evaluate the effectiveness of digital therapeutics in reducing depressive symptoms.
Otsuka and Click Therapeutics are working with Verily, the healthcare subsidiary of Google owners Alphabet, on a fully remote clinical trial testing a digital therapy as an add-on in adults with severe depression. Otsuka is on a mission to develop digital technology to treat mental… Read More »Otsuka, Click trial digital depression therapy with Google
Orexo will start a new study of its modia app – used to treat people with opioid use disorder – to test how it performs in real-world settings. The Swedish drugmaker has teamed up with consultancy ApexB.io and pharmacy group Magellan Rx Management on the… Read More »Orexo eyes real-world testing of its modia opioid use disorder app
The recommendations for the Country’s pathway towards DTx are captured in the White Paper “Digital Therapeutics, an Opportunity for Italy” The official journal of the Smith Kline Foundation, Tendenze Nuove, published the White Paper “Digital Therapeutics, an Opportunity for Italy” on 13 January 2021. The… Read More »Italy eyes Digital Therapeutics
A white paper has outlined a pathway that could allow Italy to realise the potential of digital therapeutics (DTx). The official journal of the Smith Kline Foundation, Tendenze Nuove, has published the paper entitled “Digital Therapeutics, an Opportunity for Italy” earlier this month. The book… Read More »White paper reveals pathway for digital therapeutics use in Italy
What You Should Know: – DarioHealth, a Livongo competitor acquires musculoskeletal startup Upright for $31 million to expand their chronic condition management capabilities focused on driving behavior change rather than treating the acute problem. This move will more than double revenue and create one of… Read More »DarioHealth Acquires Musculoskeletal Solution Upright for $31M
What You Should Know: – DTx and Patient Support leaders, Amalgam Rx, Inc., announce the acquisition of Avhana Health, a privately-held clinical decision support (CDS) company. Amalgam Rx, Inc., a Wilmington, DE-based Digital Therapeutics and Patient Support company, announces the acquisition of Avhana Health, a… Read More »Amalgam Rx Acquires Clinical Decision Support Platform Avhana Health – M&A
What You Should Know: – Humana Healthy Horizons™ in Kentucky announced it has selected Vida Health’s virtual diabetes management program to serve Kentucky’s Medicaid population. – Vida’s diabetes management program achieves lasting results for participants. Because chronic conditions like diabetes, obesity, and hypertension often occur simultaneously,… Read More »Humana Taps Vida Health to Power Virtual Diabetes Management for Kentucky’s Medicaid Population
In medicine, we’re getting real-time experience with what many believed was an inevitable but potentially […]
The 3rd generation pharmaceuticals- Digital therapeutics- have become a much-discussed aspect of MedTech today, as they compete with established drug-based pharmaceutical and biotech products to become therapeutic interventions for many acute and chronic diseases. Currently, many small- and mid-size companies are working to develop, manufacture… Read More »Treating Patients with Software: Digital Therapeutics
What You Should Know: – Cerner Corporation today announced with Xealth new centralized digital ordering and monitoring for health systems, starting with Banner Health, to foster digital innovation. – Health systems can prescribe digital therapeutics, smartphones, and internet apps directly within the EHR to address… Read More »Cerner, Banner Health, Xealth Partner to Simplify How Clinicians Prescribe Digital Health
Freespira Secures $10M for FDA-Cleared Digital Therapeutic to Eliminate Panic Attacks, PTSD Symptoms
What You Should Know: – Lightspeed Venture Partners, the VC behind Nest and GrubHub, is leading a $10 million round for Freespira, an FDA-cleared digital therapeutic proven to significantly reduce or eliminate panic attacks and PTSD symptoms by training users to normalize respiratory irregularities. –… Read More »Freespira Secures $10M for FDA-Cleared Digital Therapeutic to Eliminate Panic Attacks, PTSD Symptoms
What You Should Know: – Pear Therapeutics today announced that it has successfully closed an $80 million Series D financing led by SoftBank Vision Fund 2. – Pear is the leader in prescription digital therapeutics and the first company to receive FDA authorization for a… Read More »Pear Therapeutics Raises $80M to Advance Prescription Digital Therapeutics
What You Should Know: – UCB has selected Medisafe to develop branded digital drug companions for antiepileptic medications, marking the company’s official entry into the digital therapeutics space. – The initial collaboration will primarily be focused on their antiepileptic medications, but they are exploring its… Read More »UCB Taps Medisafe to Develop Branded Digital Drug Companions for Antiepileptic Medications
The healthcare system is running at its limits in many countries worldwide. One reason is the growing demand for healthcare, largely driven by the rise of chronic diseases. COVID-19 has further underscored just how stretched the system is today. Is there any solution to the… Read More »Digital therapeutics: Why human psychology is key to adoption
After receiving FDA clearance in March, Pear began marketing its prescription digital therapeutic for insomnia. It’s available by prescription only.
It’s day two of digital health innovation conference Frontiers Health, which will be mainly held online because of the COVID-19 pandemic. This year Frontiers will be a global Hybrid conference. In line with the “new normal” situation, the format of the 2020 edition will be hybrid combining online global streaming together with offline events and… Read More »Frontiers Health 2020 day two
Digital health innovation conference Frontiers Health kicks off its 2020 edition this week, although the majority of the conference will be held online because of the COVID-19 pandemic. This year, Frontiers will be a global Hybrid conference. In line with the “new normal” situation, the… Read More »Frontiers Health 2020 day one
There isn’t enough evidence to suggest that digital therapies for people with opioid use disorder (OUD) can improve on standard interventions, according to the Institute for Clinical and Economic Review. The US cost-effectiveness watchdog has concluded in an evidence report that none of three digital… Read More »Digital therapies for opioid use disorder need more data, says ICER
What You Should Know: – Apstar Pharma acquires the assets of respiratory health company Cohero Health to expands its digital portfolio with a focus on respiratory disease management. – Cohero Health develops digital tools and technologies to improve respiratory care, reduce avoidable costs, and optimize… Read More »Aptar Pharma Acquires the Assets of Respiratory Startup Cohero Health
The digital health startup released the results of a 599-person randomized clinical trial on Tuesday. It found a statistically significant reduction in participants’ weight and hemoglobin A1c levels.
Most of the digital health experts we spoke to for this issue of Deep Dive made one thing clear – no one can really say what the future holds for digital tech in the pharma and healthcare industries. But this isn’t necessarily a bad thing… Read More »Deep Dive: Digital Health Innovation 2020
The Los Angeles-based startup received a breakthrough device designation from the FDA for using VR to manage chronic pain. It recently published the results of a 92-person virtual trial testing VR for pain management at home.
What You Should Know: – FDA awards AppliedVR Breakthrough Device designation for treating treatment-resistant fibromyalgia and chronic intractable lower back pain – AppliedVR’s EaseVRx program helps patients learn self-management skills grounded in evidence-based cognitive-behavioral therapy (CBT) principles and other behavioral methods. AppliedVR, a pioneer advancing… Read More »FDA Grants AppliedVR Breakthrough Designation for Virtual Reality Chronic Pain Treatment
Akili has new data from its childhood hyperactivity therapeutic video game EndeavorRx, as the company builds a case for the technology with longer-term trial data. The company announced several new data readouts, including outcomes data from the STARS-Adjunct trial, a multi-site open-label study testing EndeavorRx… Read More »Akili presents new real-world data from therapeutic ADHD video game
The deal with Roche subsidiary Genentech is likely not the last for Genesis Therapeutics, which is based on AI research undertaken at Stanford. Such partnerships are potentially lucrative for drug-discovery startups.
What You Should Know: – 65% of patients say they will wait to receive the forthcoming COVID-19 vaccine even if it becomes available before the end, according to a new Medisafe survey. – Consumers cited greater trust in Dr. Anthony Fauci and established protocols as… Read More »Consumers Cite Trump as Leading Driver of COVID-19 Vaccine Skepticism
Digital therapeutics are clinically validated applications / software / online programs that have demonstrated the capability to facilitate positive outcomes when used in the prevention / treatment / management of diseases / clinical conditions. These therapeutics are designed to engage patients in personalized treatment or… Read More »Digital Therapeutics: Key Concepts and Regulations to Tackle COVID-19 Pandemic
The Silicon Valley startup plans to start its registration-directed study of Limbix Spark in the earlier part of next year and – if successful – would anticipate FDA clearance in early 2022.
Chance Scott, a Director in life sciences at Guidehouse, talks about some of the challenges digital health innovators face, from reimbursement by private plans to the future of reimbursement for other telehealth tools and digital therapeutics.
The recent decades have shown an accelerated development and evolution in the technology world, leading to unexpected growth in digital health companies. The Digital Therapeutics companies aid patients to schedule appointments, view medical records and seek medical advice without visiting clinics or hospitals. With the… Read More »Top 20 Innovative Digital Therapeutics Companies of 2019
What You Should Know: DarioHealth raises $28M in institutional financing intended to finance growth of their digital therapeutics B2B market share with employers, health insurance plans, and healthcare providers. The company sold 2,969,266 shares of common stock and, to certain investors in lieu thereof, pre-funded… Read More »Digital Therapeutics Company DarioHealth Raises $28M to Expand Market Share
Several digital therapy and digital health firms have been selected to join a group of startups by the innovation platform, Kickstart, linking them with a range of investors in an initiative beginning in autumn. The digital therapy companies include SidekickHealth and Kaia Health, focusing on… Read More »Digital therapy firms link up with Swiss accelerator Kickstart
The companies will test Biofourmis’ sensor and artificial intelligence system in a clinical trial of more than 120 women with endometriosis.
Shots: The two companies collaborated to develop and distribute innovative digital therapeutics supporting people with diabetes on biologics therapy. The collaboration allows Biocon to offer Insulia to T2D patients across several markets globally Biocon aspires to reimagine the patient ecosystem by developing a technology-dependent operating… Read More »Biocon Collaborates with Voluntis on Digital Therapeutics for Insulins
DarioHealth, Williams Medical Partner to Expand Digital Therapeutics Platform Across the UK and Ireland
What You Should Know: – Dario Health enters strategic partnership with Williams Medical marking its expansion into the UK remote patient monitoring market across the UK and Ireland. – Williams Medical is the leading provider of medical goods and services to primary care in the… Read More »DarioHealth, Williams Medical Partner to Expand Digital Therapeutics Platform Across the UK and Ireland
What You Should Know: – 40 percent of the global disease burden could be addressed with known interventions, but that leaves 60 percent unaddressed. – As part of the recent McKinsey report Prioritizing health: A prescription for prosperity, the McKinsey Global Institute identified ten promising… Read More »10 Healthcare Innovations That Can Reduce Total Disease Burden 6-10% by 2040
What You Should Know: – Repurpose.AI, has partnered with Scripps Research to discover drug candidates that may be repurposed to treat COVID-19. – The partnership will leverage Repurpose.AI’s ActivPred AI Drug Discovery Platform, an unbiased drug, target, and disease agnostic digital chemistry engine, to discover… Read More »Scripps Research, Repurpose.AI Partner to Develop COVID-19 Therapeutics